More US patients with kidney failure started, stayed on, and switched to peritoneal dialysis following a payment policy implemented in 2011 by Medicare. The findings, which appear in an upcoming issue of CJASN, suggest that ...
Nov 21, 2019
0
2
(HealthDay)—The vast majority of group medical practices report that regulatory requirements, including prior authorization and quality payment programs, are burdensome, according to a survey released by the Medical Group ...
Nov 6, 2019
0
0
If Medicare capped funds for Graduate Medical Education (GME) at the rate of $150,000 per resident, the move would free up more than $1 billion a year, according to a study published today in JAMA Internal Medicine. Medicare ...
Oct 7, 2019
0
3
An interdisciplinary team of Indiana University scientists studying Medicare data have found an association between health care industry payments to medical providers for non-research expenses and what these providers charge ...
Sep 20, 2019
1
93
(HealthDay)—In 2017, about half of physician directors of National Cancer Institute (NCI)-designated cancer centers received industry payments, according to a research letter published online Aug. 5 in JAMA Internal Medicine.
Aug 15, 2019
0
0
Use of a class of pain drugs called gabapentinoids has increased more than three-fold between 2002 and 2015.
Jul 9, 2019
1
0
Pharmaceutical companies' payments to doctors may be influencing them to prescribe more expensive, brand-name versions of the pain drug gabapentin, a team of researchers report in the July 8 issue of JAMA Internal Medicine, ...
Jul 8, 2019
0
3
Findings from a new study conducted by a team of researchers at Dartmouth's Geisel School of Medicine and published in the July issue of Health Affairs, shows that while the number and variety of contracts held by Accountable ...
Jul 1, 2019
0
0
A team of researchers led by a member of the University of Colorado School of Medicine faculty at the Anschutz Medical Campus examined post-advisory financial relationships between U.S. physicians who advised FDA committees ...
Jun 10, 2019
0
0
From 2012 to 2016 the drug industry donated over £57 million to UK patient organisations, with priority given to a small number of organisations supporting commercially high profile conditions like cancer, reveals an analysis ...
May 22, 2019
0
2
